VIGAMOX® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

Corynebacterium species*
Micrococcus luteus*
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus haemolyticus
Staphylococcus hominis
Staphylococcus warneri*
Streptococcus pneumoniae
Streptococcus viridans group
Acinetobacter Iwoffii*
Haemophilus influenzae
Haemophilus parainfluenzae *
Chlamydia trachomatis

*Efficacy for this organism was studied in fewer than 10 infections.

Instill one drop in the affected eye 3 times a day for 7 days.

Dosage Forms and Strengths

4 mL bottle filled with 3 mL sterile ophthalmic solution of moxifloxacin hydrochloride, 0.5% as base.

VIGAMOX® solution is supplied as a sterile ophthalmic solution in Alcon's DROP-TAINER® dispensing system consisting of a natural low density polyethylene bottle and dispensing plug and tan polypropylene closure. Tamper evidence is provided with a shrink band around the closure and neck area of the package.

3 mL in a 4 mL bottle - NDC 0065-4013-03

Storage: Store at 2°C- 25°C (36°F - 77°F).

Manufactured by Alcon Laboratories, Inc. Fort Worth, TX 76134 USA. Licensed to Alcon, Inc. by Bayer Schering Pharma AG.

Last reviewed on RxList: 10/24/2011
This monograph has been modified to include the generic and brand name in many instances.